基于超声波检查的他类药物的使用和非酒精性脂肪性肝病的发展和进展

Baoyu Feng1, Fengde Li2, Yanqi Lan1

  • 1Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences; School of Basic Medicine Peking Union Medical College, Beijing 100730, China.

概括

静止剂的使用可能会降低非酒精性脂肪肝疾病 (NAFLD) 发生和进展的风险. 这表明他类药物可能在NAFLD预防中发挥作用,特别是在心血管风险低至中等的人群中.